These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12621596)

  • 1. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G
    Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone: a potential comparator for the panicogenic effects of pentagastrin and CCK?
    Coupland N; Malizia A; Bailey J; Nutt D
    Biol Psychiatry; 1996 Mar; 39(6):465-6. PubMed ID: 8679797
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of propranolol on symptom and endocrine responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychoneuroendocrinology; 2004 Oct; 29(9):1163-71. PubMed ID: 15219640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.
    Coupland N; Zedkova L; Sanghera G; Leyton M; Le Mellédo JM
    J Psychiatry Neurosci; 2001 May; 26(3):247-51. PubMed ID: 11394194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
    Le Melledo JM; Perez-Parada J; Morrow J; Bellavance F; Lara N; Jahandar F; Granger R; Tait G; McManus K
    J Psychopharmacol; 2011 Jan; 25(1):71-7. PubMed ID: 19825898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
    McCann UD; Slate SO; Geraci M; Uhde TW
    Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K; Tait GR; Bellavance F; Le Mellédo JM
    J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
    Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
    Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between respiratory, endocrine, and cognitive-emotional factors in response to a pharmacological panicogen.
    Lyubkin M; Giardino ND; Abelson JL
    Depress Anxiety; 2010 Nov; 27(11):1011-6. PubMed ID: 20721903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
    van Vliet IM; Westenberg HG; Slaap BR; den Boer JA; Ho Pian KL
    Biol Psychiatry; 1997 Jul; 42(1):76-8. PubMed ID: 9193745
    [No Abstract]   [Full Text] [Related]  

  • 11. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users.
    Bernik MA; Gorenstein C; Vieira Filho AH
    J Psychopharmacol; 1998; 12(2):146-50. PubMed ID: 9694026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
    Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
    Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
    Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin.
    Tait GR; McManus K; Bellavance F; Lara N; Chrapko W; Le Mellédo JM
    Psychoneuroendocrinology; 2002 May; 27(4):417-29. PubMed ID: 11911996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Biol Psychiatry; 1999 Feb; 45(3):321-6. PubMed ID: 10023509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine challenge test in panic disorder and depression with panic attacks.
    Nardi AE; Lopes FL; Valença AM; Freire RC; Veras AB; de-Melo-Neto VL; Nascimento I; King AL; Mezzasalma MA; Soares-Filho GL; Zin WA
    Compr Psychiatry; 2007; 48(3):257-63. PubMed ID: 17445520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
    Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychiatry Res; 2004 May; 126(3):189-95. PubMed ID: 15157745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
    Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.